Announcement on Obtaining Government Subsidies
Filed with SSE · · 1 page · Chinese
Shandong Lukang Pharmaceutical Co., Ltd. on 6ix
Earlier from Shandong Lukang Pharmaceutical
- Prospectus for Issuance of A-shares to Specific Objects in 2024 (Registration Draft)
- Announcement on the Company and Its Holding Subsidiaries Being Selected as Successful Bidders in the 11th Round of National Centralized Drug Procurement
- Report for Q3 2025
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Obtaining Registration Approval of Application for Issuance of Shares to Specific Objects by China Securities Regulatory Commission
Later from Shandong Lukang Pharmaceutical
- Announcement on Signing Trademark License Agreement with Related Parties and Related Party Transactions
- Indicative Announcement on the Issuance of A-shares to Specific Objects in 2024
- Announcement on the Company and Its Wholly-Owned Subsidiary Signing the Fundraising Special Account Custody and Supervision Agreement
- Announcement on the Results of Issuing Shares to Specific Objects and Changes in Capital Stock
- Announcement on Using Partial Idle Raised Funds to Temporarily Supplement Current Capital
Follow Shandong Lukang Pharmaceutical into a list and get an email when it puts out news.
Follow Shandong Lukang Pharmaceutical